Sickle Cell Disease
Conditions
Interventions
Women with sickle cell disease (DF) will receive contraceptive guidance and will be offered the methods available for free choice of the participant, respecting the eligibility criteria of the World H
E02.875.194
E02.875.194.910
Sponsors
Instituto de Medicina Integral Prof. Fernando Figueira
Instituto de Medicina Integral Prof. Fernando Figueira
Eligibility
Sex/Gender
Female
Age
15 Years to 40 Years
Inclusion criteria
Inclusion criteria: Women with Sicle Cell Disease; Age between fifteen and forty years; Woman with sexual activity; Desire for contraception
Exclusion criteria
Exclusion criteria: Women with difficulty understanding the questions included in the questionnaire at the initial moment of the research; Women who have the HbSC genotype; Women using prophylactic continuous blood transfusion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease of painful crisis frequency in the period of two years, verified by the record of painful crises, from the observation of a diminish of at least 20% in the post-intervention measurement in the progestin-only group | — |
Secondary
| Measure | Time frame |
|---|---|
| Decreased frequency of headache in the two-year period, verified by headache record, from the observation of a decrease of at least 10% in post-intervention measurement in the progestogen group;Occurrence of pregnancy at any time in the study, verified by clinical suspicion of gestation and laboratory evidence of positive beta-HCG test in all groups participating in the research. | — |
Countries
Brazil
Contacts
Public ContactAriani;Flavia Souza;Carvalho da Silva
Instituto de Medicina Integral Prof. Fernando Figueira;Instituto de Medicina Integral Prof. Fernando Figueira
Outcome results
None listed